Talking Euretina: Recent Episodes
Whipsmart Media
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
In tertiary practice, masquerades account for around 5% of uveitis cases — and missing one can cost sight, or life. Prof Bahram Bodaghi is joined by Prof Elisabetta Miserocchi and Prof Isabelle Audo on vitreoretinal lymphoma, the limits of diagnostic vitrectomy, IL-10:IL-6 ratios and MYD88, the paraneoplastic retinopathies CAR, MAR and BDUMP, and the inherited retinal diseases that quietly mimic inflammation. Essential listening before reaching for steroids
The Euretina Innovation Spotlight returns to Vienna on 30 September, bringing clinicians, industry, investors and regulators around one table. Prof. Anat Loewenstein, Prof. Nicole Eter and Dr. Kourous Rezaei tell Jonathan McCrea why innovation in retina is moving faster than ever, what the return of the EMA's Jane Mosley means for bridging Europe and the US, and why this exchange of ideas is something a traditional congress simply can't offer
Anti-VEGF has transformed how we treat retinopathy of prematurity — but at what long-term cost? Dr Kanmin Xue chairs a global discussion with Dr Domenico Lepore, Prof Wei-Chi Wu and Prof Andreas Stahl on injections versus laser, the RAINBOW and FIREFLEYE trial data, managing peripheral avascular retina, and why these babies may need follow-up for life. A frank look at the questions the evidence hasn't yet answered.
A diagnosis of uveal melanoma during pregnancy forces an agonising question: treat now, or wait? Dr Emine Kiliç chairs a multidisciplinary discussion with Dr Iwona Rospond-Kubiak (Poznań), Prof. Antonia Joussen (Charité, Berlin) and radiation oncologist Dr Adam Chicheł on plaque brachytherapy and fetal radiation exposure, how gestational age shapes timing, and the reassuring — if limited — evidence on placental spread and maternal survival.
Euretina will shortly relaunch the Women in Retina survey, building on the first dataset. In this podcast, Prof. Anat Loewenstein, Dr Federica Fossataro and Prof. Nicole Eter explore what has changed since the original 2021 study, what's new and why participation from the whole community - women and men alike - is essential to measuring real progress. The Women In Retina Initiative is sponsored by Bayer.
New therapies are reshaping geographic atrophy—but are trial endpoints keeping pace with clinical reality? Anat Loewenstein is joined by Sobha Sivaprasad and Kristina Pfau to examine how success in GA is measured, from lesion growth to functional vision. The panel explores microperimetry, contrast sensitivity, and emerging tools that may better reflect meaningful patient outcomes.
A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific approaches
Three former mentees of the EURETINA Mentorship Programme share how the initiative helped shape their careers in retinal research and clinical practice. Özge Yanık Odabaş, Karolina Motloch and Omer Trivizki discuss mentorship, international collaboration, and the opportunities created through the programme’s growing alumni network. Their experiences highlight how structured mentorship can accelerate professional development for the next generation of retina specialists
Artificial intelligence is rapidly reshaping retina care — but where does it truly add value in daily practice? Professors Tien Wong and Daniel Ting join Stela Vujosevic to explore how AI is moving beyond screening into risk stratification, clinical decision support, and home monitoring. From infrastructure challenges to real-world implementation, this episode offers practical insights for retina specialists preparing for an AI-enabled future
Artificial intelligence is rapidly reshaping how we screen, classify, and treat diabetic retinal disease. Professor Aude Couturier, Professor Edoardo Midena, and Professor Reinier Schlingemann discuss real-world AI applications in diabetic retinopathy — from population screening and imaging biomarkers to phenotyping and precision treatment in diabetic macular oedema
What drives leading retina specialists to trade the clinic for corporate innovation? In this episode, Euretina Board member Kourous Rezaei speaks with Jay Duker (CEO, Eyepoint), Sascha Fauser (SVP, Roche), and Marion Munk (CSO, Gutblick Group; CMO, Isarna Therapeutics) about their transitions from clinical practice to industry. Together they share insights on leadership, research, and the evolving relationship between academia and biotechnology in shaping the future of retinal therapeutics
In this episode Professors Dean Eliott, Grazia Pertile, and José García-Arumí join chair Kourous Rezaei to explore how surgical mastery is built through intuition, preparation, and reflection. They share practical insights on mentorship, focus, teamwork, and managing stressful cases — from avoiding coffee before surgery to resetting after complications — revealing that great surgeons are defined not just by skill, but by judgment, patience, and care for the patient
In this first-ever debate edition of Talking Euretina, Dr Rumana Hussain (Liverpool Ocular Oncology Centre) introduces Professors Arun Singh (Cole Eye Institute, Cleveland Clinic), Heinrich Heimann (Liverpool Ocular Oncology Service) and Bertil Damato (Moorfields Eye Hospital) as they debate one of ocular oncology’s most enduring questions — when to operate on small choroidal melanomas. The panel examines diagnostic uncertainty, genetic risk and patient choice in determining when to treat.
Retinal diseases disproportionately affect certain populations—yet these groups are underrepresented in research. In this episode, Dr. Christiana Dinah chairs a global panel including Drs. Adrienne Scott, Charles Wykoff and Jeremiah Brown to explore the systemic and structural barriers to inclusion in retina trials, and why the stakes for equity have never been higher
In this episode, Prof. Frank Holz leads a panel discussion on a major leap forward in retinal prosthesis: the Prima system for geographic atrophy. Joined by Dr. Mahi Muqit and Prof. Lars-Olof Hattenbach, they explore how their extraordinary wireless subretinal implant is restoring visual perception in late-stage AMD.
In this episode, Profs. Lejla Vajzovic (USA), Sandrine Zweifel (Switzerland), and Heinrich Heimann (UK) reflect on a fantastic few days in Paris and share their highlights from the 2025 programme for you to watch back through the portal.
Euretina President Prof. Anat Loewenstein speaks with Prof. Ursula Schmidt-Erfurth, 25th Euretina Lecturer, about her groundbreaking career in retinal disease, from imaging innovations to AI-driven early detection. They discuss the EU-funded iScreen project, the future of AMD management, and the significance of two women presidents (past and present) as Euretina celebrates its 25th anniversary in Paris
Ahead of his Gisbert Richard Lecture at this year’s Euretina Congress in Paris, Prof. Jean-François Korobelnik joins Prof. Nicole Eter to reflect on a career at the forefront of retinal research. From surgical breakthroughs to his leadership of the E3 consortium, and his cautious optimism for AI, Prof. Korobelnik shares insights on past progress and future priorities in retina
Ahead of her Kreissig Award Lecture at the Euretina Congress in Paris, Professor Maria Berrocal (Puerto Rico) joins Euretina past president Alistair Laidlaw to discuss why time-tested treatments like PRP and scleral buckling still matter. They explore the risks of over-reliance on anti-VEGF in proliferative diabetic retinopathy, the decline in buckle training, and how chandelier techniques could revive it
In this thought-provoking episode, Professor Tariq Aslam and Retina International’s Avril Daly join Jonathan McCrea to explore the emotional and psychological dimensions of retinal disease. From the power of empathy in clinical care to the need for integrated mental health services, the discussion highlights why supporting patients beyond the medical chart is more vital than ever—especially in an AI-driven world.
Ahead of her Ophthalmologica Lecture at this year’s Euretina Congress, Dr. Maria Vittoria Cicinelli joins Professor Bahram Bodaghi to explore the evolving understanding of white spot syndromes. From classic presentations of punctate inner choroidopathy (PIC) to emerging imaging insights and therapeutic uncertainties, the conversation highlights unmet needs, research gaps, and practical implications for clinicians managing posterior uveitis
In this episode, Prof. Martin Zinkernagel and Dr. Matias Iglicki spotlight Ophthalmologica’s new article collection on submacular hemorrhages. They explore key findings from four studies covering imaging, surgical strategies, and real-world outcomes, offering timely insights into managing this vision-threatening condition.
Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea
When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the importance of multidisciplinary collaboration in high-risk cases
What are hyperreflective foci, and why do they matter in AMD? Prof. Stella Vujosevic is joined by Prof. Christine Curcio (University of Alabama at Birmingham) and Prof. Srinivas Sadda (Doheny Eye Institute, UCLA) to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related macular degeneration
What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF
Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Prof Jens Folke Kiilgaard (Denmark) and Dr Emine Kilic (Netherlands) join Prof Antonia Joussen (Germany) to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. We also discuss the role of adjuvant and neoadjuvant therapies and emerging T-cell therapies. Join us for an insightful discussion on the future of uveal melanoma treatment
In this episode, Chair Alistair Laidlaw (UK) chats to Mario Romano (Italy) and Stratos Gotzaridis (Greece) about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR)
In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr Arshad Khanani (USA) about clinical trials, long term-data and the importance of personalising the treatment to the patient
In this second episode looking at highlights from the Barcelona congress, we'll hear about AI and sustainability in ophthalmology from Prof Jean-Francois Korobelnik of University Hospital Bordeaux
Barcelona, We love you! Over the next few episodes, we'll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals
In this episode, Prof Nicole Eter (Germany) speaks with Dr Yousif Subhi, this year's Ophthalmologica lecture about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research
In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein
Ahead of his prestigious Gisbert Richard lecture at this year's upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database
In this episode, Drs Kristina Pfau (Switzerland) and Elon Van Dijk (Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They'll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers
In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar, Principal Optometrist at Moorfields and UCL
In this podcast, Bart Leroy and Mark Pennesi discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease).
In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)
In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research? Chaired by Jonathan McCrea
In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK)
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
In this podcast episode, we will dig into the subject of radiation maculopathy, the most common complication following the irradiation of intraocular tumours, with a panel of ocular oncologists from across Europe: Hibba Quhill (UK), Iwona Rospond-Kubiak (Poland), Emine Kilic (Netherlands) and Raffaele Parrozzani (Italy).
In this episode we look at two very interesting papers published in the latest editions of Ophthalmologica - Martin Busch presents his work on using microRNA as biomarkers for retinal disease and the panel discuss Christina Weisheit's paper on Co2 emissions from the ophthalmic OR. Chaired by Patricia Udaondo, Matias Iglicki and Andreas Ebneter.
Links to papers:
https://karger.com/oph/article/246/3-4/169/861433/High-Impact-Actions-to-Reduce-the-Carbon-Dioxide
https://karger.com/oph/article/246/3-4/227/861182/Circulating-MicroRNAs-as-Biomarker-for-Vessel?searchresult=1
Fresh from his exciting win of the Lasker Award - often dubbed the American Nobel Prize - Professor David Huang (USA) - the inventor of optical coherence tomography (OCT) - joins Prof Pearse Keane (UK) and Tunde Peto (Hungary/UK) to talk about how he and colleagues developed the technology and about the impact it has had on retinal medicine
As applications open for the Euretina Retinal Medicine Clinical Research Award, we hear about the award from Euretina EVP, Dara Conlon. We also gain interesting insights from previous winners Camiel Boon (Netherlands) and João Pedro Marques (Portugal) to see how the award has furthered their research.
In this podcast Euretina President, Mr Alistair Laidlaw and Euretina EVP Dara Conlon explore the highlights of this year's congress which is on track to be the biggest and most exciting meeting yet!
In this episode, journalist Ramadan Younis and his executive producer Simon Cox tell us about their far-reaching BBC documentary. "Blind Faith" exposes the international practice of defrauding patients of Retinitis Pigmentosa with false hopes of treatment or cure with little or no evidence of efficacy. They are joined by Prof Robert McLaren of the University of Oxford, who consulted on the documentary and evaluated the scientific claims being made by bad actors in the programme. You can watch the documentary here: https://www.bbc.co.uk/programmes/p0f95ky3
In this episode, we’re going to dig into the subject of this year’s Ophtalmologica lecture which will be delivered on the Saturday afternoon at this year’s congress in Amsterdam. Professor Maximilan Pfau is a clinician with a specialism in AMD and Inherited Retinal diseases in the Department of Ophthalmology at the University Eye Hospital, Basel, Switzerland. He's joined by Editor in Chief of the Ophthalmologica Journal; Professor Martin Zinkernagel
In this episode, we head to Asia to hear from colleagues in Japan, Singapore and South Korea about their experiences treating PCV and Pachychoroid in different populations. The podcast is chaired by Prof Taiji Sakamoto (Japan) and Prof SeungYoung Yu (South Korea) who are joined by Prof Gemmy Cheung and Prof Adrian Koh (Singapore)
In this podcast, we hear from Euretina Keynote Bertil Damato (UK/Sweden) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair - UK)
In this podcast, we'll be hearing about an exciting new event taking place in Amsterdam at the Euretina Congress in October; the inaugural Euretina Innovation Summit (EIS). Kourous Rezaei (USA) and Anat Loewenstein (Israel) - two members of the organising committee - will discuss the programme and motivation behind the event with chair Frank G Holz (Germany)
In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas
In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross University Hospital, Lyon
In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.
In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica.
Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger).
Chaired by Jonathan McCrea
In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)
In this episode, Sigfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Royston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?
Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).
In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes
In this podcast, Mark Penessi is joined by Isabelle Audo and Bart Leroy to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
In this episode, Euretina President Alistair Laidlaw chairs a discussion with Nicole Eter (München University Medical Centre) and Brendan Strong, Head of Education at Agenda about the new EBO examination.
In this podcast, we hear from author and leadership coach Sally Helgesen, author of Why Women Rise about the challenges facing aspiring women leaders. The interview is followed by a discussion with Prof Anat Loewenstein (Israel) and Dr Ruth Freeman (Science Foundation Ireland) about the Women in Retina programme and how to move the dial when it comes to equality of opportunity in medical research. Guests: Sally Helgesen (Author, USA) Prof Anat Loewenstein (Israel) and Dr Ruth Freeman (Science Foundation Ireland)
In this in-depth podcast, Euretina President-Elect Ramin Tadayoni (France) chairs a discussion with Kyoko Ohno Matsui (Japan) and David Gaucher (France) exploring everything you need to know when dealing with the “bad guy” in myopia - Staphyloma.
Panel: Prof Ramin Tadayoni, University Of Paris Cite, Lariboisière, Saint Louis And Adolphe De Rothschild Foundation Hospitals, France
Kyoko Ohno Matsui Tokyo Medical And Dental University, Japan
David Gaucher Dept Of Ophthalmology, University Of Strasbourg, France
In this episode, Hibba Quhill (UK) explores each of the components that make up the MOLES system used for management of melanocytic choroidal tumours with the system's originator, Bertil Damato (UK/Sweden).
In this episode we will look at the Derby and Oaks trials; two trials looking at geographic atrophy associated with AMD. The session is chaired by Professor Frank Holz (Germany), featuring Professors Adnan Tufail (UK) and Sandrine Zweifel (Switzerland).
Worried you missed out on some great content at EURETINA? Don't worry! In this episode, we look back on the best Euretina sessions from the Congress. Joining us to give us their highlights from Hamburg are: Alistair Laidlaw, Euretina President, Ramin Tadayoni (France) and Kourous Rezaei (USA)
In this episode, we catch up with Professors Camiel Boon, Tunde Peto and Dr Patricia Udaondo (New University and Polytechnic Hospital La Fe, Valencia) fresh from an incredible event in Hamburg to hear all about their highlights of the congress. They'll share their standout sessions that you need to catch up on via the Euretina portal at www.euretina.org
Euretina 2022 Hamburg highlights:
Tunde Peto:
Euretina Lecture - Sobha Sivaprasad
Euretina Session 10: Inherited Retinal Diseases
Subspecialty Sessions - Euretina IRD ERN-EYE session
Camiel Boon:
Subspecialty Sessions - Euretina IRD ERN-EYE session
Euretina Session 14 - CSC
World Retina Day - Singapore Society of Ophthalmology Session:
Patricia Eduaondo:
Euretina session 4 - Vitreoretinal Surgery I: Management of silicone oil complications
Euretina session 8 - Late Breakings
Euretina session 15 - Vitreoretinal Surgery II
World Retina Day - Spanish Society of Retina and Vitreous (SERV) Vitreoretinal surgery in complex trauma cases
In this episode, we will again hear from two of our keynote speakers at the Euretina congress in Hamburg this September. Prof Hiroko Terasaki (Japan) who will give the Kreissig Lecture on Sept 3rd at Euretina (interviewed by Professor Ramin Tadayoni, Euretina President Elect) and Dr Enrico Borelli (Italy) who will give the Ophthalmologica lecture (interviewed by Prof Frank Holz, Bonn, former Euretina President).
In this episode Euretina President Mr Alistair Laidlaw previews two of our keynote speakers from this year's Euretina Congress in Hamburg. He is joined by Professor Sobha Sivaprasad (UK) and Professor Catherine Creuzot-Garcher (France)
In this episode, we explore non-invasive imaging of retinal diseases in a discussion chaired by Dr Stela Vujosevic ( Italy). Our faculty are Dr Bianca Gerendas, Medical University of Vienna and Dr Amani Fawzi, Northwestern University of Chicago.
In this episode, we return to the topic of ocular oncology to explore choroidal naevi in daily practice, through Imaging, follow-ups and the MOLES system. This expert discussion is chaired by Heinrich Heimann who is joined by Prof Bertil Damato, Dr Rumana Hussain, Dr Iwona Rospond-Kubiak and Dr Jose Caminal.
This Journal Club is all about subretinal hemorrhaging as we take a look at 2 relevant papers and hear the latest developments of the Euretina-sponsored TIGER Study. It is chaired by Professors Grazia Pertile (Sacro Cuore Hospital Negrar, Verona) and Siegfried Priglinger (LMU Munich). They're joined by Professor Timothy Jackson (King’s College, London), Dr Emilia Maggio (Sacro Cuore Hospital Negrar, Verona) and Dr Saskia van Romunde (The Rotterdam Eye Hospital)
In this episode, Professor Sandrine Zweifel (Switzerland) and Professor Adnan Tufail (UK) chair a discussion on how imaging has affected our understanding of AMD. They discuss the impact of new biomarkers and also explore the effect of big data on this field now and into the future. Contributing faculty are Professor Christine Curcio (USA), Professor K Bailey Freund (USA) and Professor Srinivas Sadda (USA).
In this episode, Carlos Pavesio (UK) and Sofia Androudi (Greece) share their experience and insights in the diagnosis and treatment of macular edema. Chaired by Bahram Bodaghi (France).
In this episode, we hear from Brent Dykes about the importance of storytelling with data and how to implement it when communicating research. Brent is author of Effective Data Storytelling, founder of Analytics Hero and a regular contributor to Forbes.
In this episode, we explore the benefits of the Euretina Mentorship Programme. Guests are programme mentor and Euretina Board member, Dr Patricia Udaondo and Dara Conlon, Euretina Executive Vice President.
In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel (University Hospital Zurich) and Professor Usha Chakravarthy (Queen's University Belfast)
In this episode, Professors Heinrich Heimann (Liverpool University Hospital) and Jens Kiilgaard (Copenhagen University Hospital) chair a conversation about metastatic disease in uveal melanoma and a newly approved treatment, Tebentafusp. They’re joined by Dr Joseph Sacco (Liverpool University Hospital) and Dr Mette Bagger (Copenhagen University Hospital)
In this episode on inherited retinal diseases, we explore issues related to genetic testing: when it's needed, how access differs globally and when to refer patients to super specialist IRD centres. The discussion is chaired by Professor Bart LeRoy (Belgium) and Professor Isabelle Audo (Sorbonne France) with Dr Rola Ba-Abbad (Saudi Arabia) and Prof Graeme Black (UK).
In this Journal Club episode, Tunde Peto from Queen’s University, Belfast and Sebastian Wolf from Inselspital in Bern chair a discussion on key papers in retinal imaging and AI. First, Pearse Keane of University College London presents work on the use of AI in the detection of papilledema (1). Tariq Aslam from Manchester University then explores the issues arising from a 2021 paper comparing different algorithms in diabetic retinopathy screening (2).
(1): https://www.nejm.org/doi/full/10.1056/NEJMoa1917130
(2): https://pubmed.ncbi.nlm.nih.gov/33402366
In this episode, Professors Edoardo Midena (Padua University Hospital) and Reinier Schlingemann (Amsterdam UMC) chair a discussion around some of the hot topics in the subspecialty field of diabetic retinopathy. Joined by Professors Jennifer Sun (Joslin Diabetes Center, Harvard Medical School) and Jakob Grauslund (University of Southern Denmark), they discuss:
- The treatment of non-proliferative diabetic retinopathy with anti-VEGF intravitreal injections
- Faricimab, a new drug for the treatment of diabetic macular edema. The rationale and preliminary data
- Artificial intelligence in the screening of diabetic retinopathy: pearls and pitfalls
In the first of our monthly Journal Clubs, Ferdinando Bottoni and Carsten Meyer present their publications on optic disc pit maculopathy and a retinal expansion technique for persistent macular holes respectively. A short synopisis of each paper is given below.
The papers were discussed with the authors by a panel chaired by David Steel, Grazia Pertile and Marta Figueroa.
Bottoni F, Cereda M, Secondi R, Bochicchio S, Staurenghi G. Vitrectomy for optic disc pit maculopathy: a long-term follow-up study. Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):675-682.
Synopsis: In a retrospective non-comparative study of patients with optic disc pit maculopathy treated with vitrectomy alone, complete resolution of fluid in and under the fovea was achieved in 8 of 10 eyes (80%) without additional treatment. One additional patient experienced a retinal detachment requiring further surgery. In the successful cases macular detachment resolved in a mean of 14 months after surgery. Postoperative BCVA improved significantly from a mean of 0.63 logMAR compared to a preoperative mean of 0.27 logMAR. Nine eyes (82%) had a postoperative BCVA of 0.5 or better.
The authors concluded that vitrectomy with induction of alone was a safe and successful therapeutic option for the treatment of optic disc pit maculopathy.
Vitrectomy for optic disc pit maculopathy: a long-term follow-up study - PubMed (nih.gov)
Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L, Priglinger S, Hillenkamp J, Wachtlin J, Becker M, Mennel S, Koss MJ. Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study. Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2151-2161.
In a retrospective non-comparative study by 12 surgeons on 41 eyes with persistent macular holes, the authors reported on their initial surgical, anatomical and functional experience with a technique of retinal expansion by applying balanced saline solution underneath the edges of the holes to free up subretinal adhesions which they postulated had inhibited primary closure. The PMH were closed with this technique in 35 out of the 41 eyes (85%) at 6 weeks after surgery. The postoperative BCVA improved to 0.22 from 0.1 pre op. The application of SR-fluid was not associated with major intraoperative adverse effects. The authors concluded that the technique could achieve a fast and immediate anatomical closure in many cases without serious adverse events.
Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study - PubMed (nih.gov)
In this first episode, Euretina’s new president Alistair Laidlaw discusses the future strategy and vision of the society with president-elect Ramin Tadayoni and General Secretary Professor Anat Loewenstein.